Ardent Health Partners, LLC (NYSE:ARDT – Get Free Report) has been assigned an average recommendation of “Buy” from the twelve brokerages that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the company. The average 12-month price target among brokers that have covered the stock in the last year is $22.00.
A number of equities research analysts have recently commented on the stock. Truist Financial lowered their price target on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a report on Monday, January 6th. KeyCorp started coverage on shares of Ardent Health Partners in a research note on Friday, October 11th. They issued an “overweight” rating and a $24.00 target price for the company. Leerink Partners increased their price target on Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 12th. Bank of America downgraded Ardent Health Partners from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $22.00 to $19.00 in a research report on Wednesday, November 6th. Finally, Stephens reiterated an “overweight” rating and set a $24.00 target price on shares of Ardent Health Partners in a research report on Thursday, September 19th.
Read Our Latest Stock Report on ARDT
Ardent Health Partners Stock Down 1.8 %
Institutional Trading of Ardent Health Partners
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Seven Grand Managers LLC purchased a new stake in Ardent Health Partners during the third quarter worth approximately $2,298,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of Ardent Health Partners in the third quarter valued at about $13,119,000. Financial Management Professionals Inc. purchased a new stake in shares of Ardent Health Partners during the 3rd quarter valued at about $50,000. Charles Schwab Investment Management Inc. purchased a new stake in shares of Ardent Health Partners during the 3rd quarter valued at about $526,000. Finally, BNP Paribas Financial Markets acquired a new position in Ardent Health Partners during the 3rd quarter worth approximately $42,000.
About Ardent Health Partners
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Recommended Stories
- Five stocks we like better than Ardent Health Partners
- What is a Dividend King?
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- Insider Trades May Not Tell You What You Think
- How Do Stock Buybacks Affect Shareholders?
- How to trade using analyst ratings
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.